In contrast, tumors with irreversible genetic lesions associated with loss of MHC surface expression will not be able to efficiently present new antigenic peptides to T cells, thereby subsequently favoring tumor and/or metastases progression. This evidence concerns the gene HLA-C and neoplasm.